The value for the G-CSF group was also higher than the decrease observed in a study in 32 patients with multiple myeloma receiving the same mobilization regimen and for whom PBSC collection was performed with the same apheresis system but with the MNC protocol (38.1%) [35]. The gene discussed is CSF3; the disease is AL amyloidosis.